We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Molecular Diagnostics

Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

A newly introduced extraction kit enables consistent, automation-ready isolation of cell-free DNA from commonly used biofluids. More...
20 Feb 2026
Image: The model estimates when Alzheimer’s symptoms will begin based on the accumulation of amyloid and tau proteins in the brain (Photo courtesy of Sara Moser/WashU Medicine)

Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms

A single blood test model can predict Alzheimer’s symptom onset years in advance. More...
20 Feb 2026
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

An AI-driven liquid biopsy tool enhances pediatric brain tumor diagnosis. More...
19 Feb 2026
Image: The assay evaluates tumor-derived total nucleic acid extracted from CSF and detects multiple biomarker classes (Photo courtesy of Shutterstock)

New CSF Liquid Biopsy Assay Reveals Genomic Insights for CNS Tumors

A newly validated assay enables comprehensive genomic characterization of central nervous system malignancies from cerebrospinal fluid. More...
19 Feb 2026
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

A new AI biomarker improves chemotherapy prediction in triple-negative breast cancer. More...
19 Feb 2026
mage: The AI-derived MYCN niche score predicts liver cancer risk before tumors form (Photo courtesy of Adobe Stock)

AI-Powered Biomarker Predicts Liver Cancer Risk

A machine-learned biomarker identifies those at high risk for liver cancer. More...
19 Feb 2026
Image: The LIAISON NES Group A Strep assay is intended for use on the LIAISON NES POC molecular diagnostics system (Photo courtesy of Diasorin)

Group A Strep Molecular Test Delivers Definitive Results at POC in 15 Minutes

A Group A Streptococcus test provides clear, actionable results directly at the near-patient setting in 15 minutes. More...
18 Feb 2026
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.